$120.78
+1.69 (+1.41%)
At Close: Jun 11, 2026
Covid-19 Impact on Blood Serum Market Value Projected to Expand by 2027 | Sigma-Aldrich, Merck
06:02pm, Thursday, 25'th Nov 2021 OpenPR
Another exploration Titled "Worldwide Blood Serum 2019-Market Research Report" gives the Professional and inside and out assessment of extent of momentum and future market and survey of Product Specification, showcase pattern , item type and creation investigation considering central point,
Worldwide Human Papillomavirus Vaccine Industry to 2026 - Approvals of New HPV Vaccines Presents Opportunities - ResearchAndMarkets.com
05:39pm, Thursday, 25'th Nov 2021 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Human Papillomavirus Vaccine Market (2021-2026) by Type, Indication, Diseases, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com''s offering. The Global Human Papillomavirus Vaccine Market is estimated to be USD 3.25 Bn in 2021 and is expected to reach USD 4.47 Bn by 2026, growing at a CAGR of 6.6%. Companies Mentioned Merck & Co., Inc., A-S Medication Solutions LLC GlaxoSmithK
Allergic Rhinitis Treatment Market Overall Study Report 2021-2028 | Merck & Co., Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline PLC
02:16pm, Thursday, 25'th Nov 2021 OpenPR
Global Allergic Rhinitis Treatment Market Allergic rhinitis is the characteristic response to localized IgE-mediated inflammation that is triggered by exposure to an aeroallergen to which the individual is sensitized. Allergic rhinitis is further differentiated on the basis of aeroallergens that can
Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors
02:00pm, Thursday, 25'th Nov 2021 PR Newswire Asia (English)
- New investors include US life science investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, and Asia -based global healthcare investors Tybourne Capital Management and NSG Ventures - Following the most recent strategic investment of $26 million from Guardant Health, the company has now secured more than $135 million in total ahead of its planned KOSDAQ IPO next year SEOUL, South Korea , Nov. 25, 2021 /PRNewswire/ -- Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising round ahead of the company''s planned public offering on the South Korean stock market (KOSDAQ) early next year. A number of new investors have joined the round including leading US healthcare investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, as well as Asia -based global healthcare investors Tybourne Capital Management, and NSG Ventures. HealthQuest Capital invested $20 million of the total funding amount.
Atalanta Sosnoff Capital LLC Acquires New Shares in Merck & Co., Inc. (NYSE:MRK)
01:54pm, Thursday, 25'th Nov 2021 Dakota Financial News
Atalanta Sosnoff Capital LLC acquired a new position in Merck & Co., Inc. (NYSE:MRK) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 483,877 shares of the companys stock, valued at approximately $36,344,000. A number of other institutional investors and hedge funds also recently bought []
Thailand signs 500m deal to buy 50,000 courses of Molnupiravir COVID-19 medication
01:37pm, Thursday, 25'th Nov 2021 Thai PBS World
Thailands Medical Services Department signed a 500-million baht deal with MSD (Thailand) today (Thursday) to buy 50,000 courses of Mercks Molnupiravir (Lagevrio) oral anti-viral medication for the treatment of COVID-19 The post Thailand signs 500m deal to buy 50,000 courses of Molnupiravir COVID-19 medication first appeared on Thai PBS World : The latest Thai news in English, News Headlines, World News and News Broadcasts in both Thai and English. We bring Thailand to the world .
At CAGR 19.7%, CAR-T Cell Therapy Market Size to hit USD 19126.1 Mn by 2027 Says Brandessence Market Research
01:13pm, Thursday, 25'th Nov 2021 Intrado Digital Media
Key Companies for Global CAR-T Cell Therapy Market Novartis AG, Merck KGaA, Gilead Sciences Inc., TCR2 Therapeutics Inc, Bluebird Bio Inc., Sorrento Therapeutics, Fate Therapeutics, Pfizer Inc., Amgen, Celgene Corporation And More Key Companies for Global CAR-T Cell Therapy Market Novartis AG, Merck KGaA, Gilead Sciences Inc., TCR2 Therapeutics Inc, Bluebird Bio Inc., Sorrento Therapeutics, Fate Therapeutics, Pfizer Inc., Amgen, Celgene Corporation And More
Rapid-acting Diabetes Market 2021 Size, Growth Analysis Report, Forecast to 2027 | Abbott, Bayer, Eli Lilly, BD, Johnson & Johnson, Merck, Pfizer, AstraZeneca
12:49pm, Thursday, 25'th Nov 2021 OpenPR
Global Rapid-acting Diabetes Market 2021-2027 The latest research study on Global Rapid-acting Diabetes Market offers a detailed overview of the factors influencing the global business scope. Rapid-acting Diabetes Market research report shows the latest market insights, current situation analysis with upcoming
Merck & Co., Inc. (NYSE:MRK) to Post Q4 2021 Earnings of $1.22 Per Share, Truist Securiti Forecasts
12:22pm, Thursday, 25'th Nov 2021 Dakota Financial News
Merck & Co., Inc. (NYSE:MRK) Stock analysts at Truist Securiti lowered their Q4 2021 earnings estimates for Merck & Co., Inc. in a research report issued on Tuesday, November 23rd. Truist Securiti analyst R. Karnauskas now forecasts that the company will post earnings of $1.22 per share for the quarter, down from their prior []
DUBLIN--(BUSINESS WIRE)--The "Cellulitis - Global Clinical Trials Review, H2, 2021" clinical trials has been added to ResearchAndMarkets.com''s offering. This clinical trial report provides an overview of the Cellulitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Cellulitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials
Scope of Solid Phase Extraction Market Size, Status and Top Key Vendors (3M, Merck, Waters, Thermo Fisher, Agilent, PerkinElmer, JASCO, ANPEL) | Forecast to 2028
09:08am, Thursday, 25'th Nov 2021 OpenPR
Global Solid Phase Extraction Market Overview: To accomplish highest return on investment (ROI), it’s very essential to know about market parameters such as brand awareness, market landscape, possible future issues, industry trends and customer behaviour where Solid Phase Extraction Market report
Global Small Molecule Sterile Injectable Drugs Market Overview: A brilliant Small Molecule Sterile Injectable Drugs Market research report brings into focus the key market dynamics of the sector. This market study also analyzes the market status, market share, growth rate, future
Global Neurological Biomarkers Market Synopsis: By employing an exceptional Neurological Biomarkers Market report, businesses can get details about market drivers and market restraints which help them to take presumption about reducing or growing the production of particular product. When globalization is
Antiparasitic Drugs Market 2021 Size, Status and Global Outlook Ipca Laboratories Ltd, Zydus Cadila, Merck, Pfizer, GlaxoSmithKline Plc
07:30am, Thursday, 25'th Nov 2021 OpenPR
The "Antiparasitic Drugs" Market report offers qualitative and quantitative insights and a detailed analysis of market size & growth rate for all possible segments in the market. The Global Antiparasitic Drugs Industry presents a market overview, product details, classification, and
Innovative Drug Market 2021 Insights with Statistics and Growth Prediction Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis
07:18am, Thursday, 25'th Nov 2021 OpenPR
The "Innovative Drug" Market report offers qualitative and quantitative insights and a detailed analysis of market size & growth rate for all possible segments in the market. The Global Innovative Drug Industry presents a market overview, product details, classification, and
Sign In
Buy MRK